Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis

Cell Reports

Volumn 6, Issue 1, 2014, Pages 231-244

  Madzo, Jozef ^a   Liu, Hui ^a   Rodriguez, Alexis ^a   Vasanthakumar, Aparna ^a   Sundaravel, Sriram ^a   Caces, DonneBennettD ^a   Looney, TimothyJ ^a,b   Zhang, Li ^a,b   Lepore, JanetB ^a   Macrae, Trisha ^a   Duszynski, Robert ^a   Shih, AlanH ^f   Song, Chun Xiao ^c,d   Yu, Miao ^c,d   Yu, Yiting ^e   Grossman, Robert ^a   Raumann, Brigitte ^a   Verma, Amit ^e   He, Chuan ^c,d   Levine, RossL ^f   Lavelle, Don ^g,h   Lahn, BruceT ^a,b   Wickrema, Amittha ^a   Godley, LucyA ^a   more..

^a UNIVERSITY OF CHICAGO   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c THE UNIVERSITY OF CHICAGO   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g UNIVERSITY OF ILLINOIS   (United States)

^h JESSE BROWN VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL DIFFERENTIATION; CELL DISRUPTION; CELL INTERACTION; CELL LINEAGE; CELL RENEWAL; CONTROLLED STUDY; EPIGENETICS; ERYTHROPOIESIS; GENE LOCUS; GENE MUTATION; GENE REGULATORY NETWORK; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; METHYLATION; PRIORITY JOURNAL; PURIFICATION;

ANTIGENS, CD34; CELLS, CULTURED; CYTOSINE; DIOXYGENASES; DNA METHYLATION; ERYTHROID CELLS; ERYTHROPOIESIS; HISTONES; HUMANS; MUTATION; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSCRIPTION FACTORS;

EID: 84892540146     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.11.044     Document Type: Article

References (52)

1. Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., Malinge S., Yao J., Kilpivaara O., Bhat R., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147.
2. Anantharaman A., Lin I.J., Barrow J., Liang S.Y., Masannat J., Strouboulis J., Huang S., Bungert J. Role of helix-loop-helix proteins during differentiation of erythroid cells. Mol. Cell. Biol. 2011, 31:1332-1343.
3. Bauer D.E., Kamran S.C., Orkin S.H. Reawakening fetal hemoglobin: prospects for new therapies for the β-globin disorders. Blood 2012, 120:2945-2953.
4. Bock C., Beerman I., Lien W.H., Smith Z.D., Gu H., Boyle P., Gnirke A., Fuchs E., Rossi D.J., Meissner A. DNA methylation dynamics during invivo differentiation of blood and skin stem cells. Mol. Cell 2012, 47:633-647.
5. Dale, R. (2013). Metaseq 0.5. http://pythonhosted.org/metaseq.
6. Dawlaty M.M., Ganz K., Powell B.E., Hu Y.C., Markoulaki S., Cheng A.W., Gao Q., Kim J., Choi S.W., Page D.C., Jaenisch R. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 2011, 9:166-175.
7. Dev A., Fang J., Sathyanarayana P., Pradeep A., Emerson C., Wojchowski D.M. During EPO or anemia challenge, erythroid progenitor cells transit through a selectively expandable proerythroblast pool. Blood 2010, 116:5334-5346.
8. Ficz G., Branco M.R., Seisenberger S., Santos F., Krueger F., Hore T.A., Marques C.J., Andrews S., Reik W. Dynamic regulation of 5-hydroxymethylcytosine in mouse ES cells and during differentiation. Nature 2011, 473:398-402.
9. Fujiwara T., O'Geen H., Keles S., Blahnik K., Linnemann A.K., Kang Y.A., Choi K., Farnham P.J., Bresnick E.H. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 2009, 36:667-681.
10. Gu T.P., Guo F., Yang H., Wu H.P., Xu G.F., Liu W., Xie Z.G., Shi L., He X., Jin S.G., et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 2011, 477:606-610.
11. Iqbal K., Jin S.G., Pfeifer G.P., Szabó P.E. Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine. Proc. Natl. Acad. Sci. USA 2011, 108:3642-3647.
12. Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
13. Jankowska A.M., Szpurka H., Tiu R.V., Makishima H., Afable M., Huh J., O'Keefe C.L., Ganetzky R., McDevitt M.A., Maciejewski J.P. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 2009, 113:6403-6410.
14. Kang J.A., Zhou Y., Weis T.L., Liu H., Ulaszek J., Satgurunathan N., Zhou L., van Besien K., Crispino J., Verma A., et al. Osteopontin regulates actin cytoskeleton and contributes to cell proliferation in primary erythroblasts. J.Biol. Chem. 2008, 283:6997-7006.
15. Kang Y.A., Sanalkumar R., O'Geen H., Linnemann A.K., Chang C.J., Bouhassira E.E., Farnham P.J., Keles S., Bresnick E.H. Autophagy driven by a master regulator of hematopoiesis. Mol. Cell. Biol. 2012, 32:226-239.
16. Ko M., Bandukwala H.S., An J., Lamperti E.D., Thompson E.C., Hastie R., Tsangaratou A., Rajewsky K., Koralov S.B., Rao A. Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation ofhematopoietic stem cells in mice. Proc. Natl. Acad. Sci. USA 2011, 108:14566-14571.
17. Koh K.P., Yabuuchi A., Rao S., Huang Y., Cunniff K., Nardone J., Laiho A., Tahiliani M., Sommer C.A., Mostoslavsky G., et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8:200-213.
18. Krause D.S. Regulation of hematopoietic stem cell fate. Oncogene 2002, 21:3262-3269.
19. Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
20. Lettre G., Sankaran V.G., Bezerra M.A., Araújo A.S., Uda M., Sanna S., Cao A., Schlessinger D., Costa F.F., Hirschhorn J.N., Orkin S.H. DNA polymorphisms at the BCL11A, HBS1L-MYB, and beta-globin loci associate with fetal hemoglobin levels and pain crises in sickle cell disease. Proc. Natl. Acad. Sci. USA 2008, 105:11869-11874.
21. Li Z., Cai X., Cai C.L., Wang J., Zhang W., Petersen B.E., Yang F.C., Xu M. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 2011, 118:4509-4518.
22. Li X., Wang S., Li Y., Deng C., Steiner L.A., Xiao H., Wu C., Bungert J., Gallagher P.G., Felsenfeld G., et al. Chromatin boundaries require functional collaboration between the hSET1 and NURF complexes. Blood 2011, 118:1386-1394.
23. Madzo J., Vasanthakumar A., Godley L.A. Perturbations of 5-hydroxymethylcytosine patterning in hematologic malignancies. Semin. Hematol. 2013, 50:61-69.
24. Masuoka H.C., Townes T.M. Targeted disruption of the activating transcription factor 4 gene results in severe fetal anemia in mice. Blood 2002, 99:736-745.
25. Moran-Crusio K., Reavie L., Shih A., Abdel-Wahab O., Ndiaye-Lobry D., Lobry C., Figueroa M.E., Vasanthakumar A., Patel J., Zhao X., et al. Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell 2011, 20:11-24.
26. Ogawa M. Differentiation and proliferation of hematopoietic stem cells. Blood 1993, 81:2844-2853.
27. Pastor W.A., Pape U.J., Huang Y., Henderson H.R., Lister R., Ko M., McLoughlin E.M., Brudno Y., Mahapatra S., Kapranov P., et al. Genome-wide mapping of 5-hydroxymethylcytosine in embryonic stem cells. Nature 2011, 473:394-397.
28. Quivoron C., Couronné L., Della Valle V., Lopez C.K., Plo I., Wagner-Ballon O., Do Cruzeiro M., Delhommeau F., Arnulf B., Stern M.H., et al. TET2 inactivation results in pleiotropic hematopoietic abnormalities in mouse and is a recurrent event during human lymphomagenesis. Cancer Cell 2011, 20:25-38.
29. Sankaran V.G., Menne T.F., Xu J., Akie T.E., Lettre G., Van Handel B., Mikkola H.K., Hirschhorn J.N., Cantor A.B., Orkin S.H. Human fetal hemoglobin expression is regulated by the developmental stage-specific repressor BCL11A. Science 2008, 322:1839-1842.
30. Shearstone J.R., Pop R., Bock C., Boyle P., Meissner A., Socolovsky M. Global DNA demethylation during mouse erythropoiesis invivo. Science 2011, 334:799-802.
31. Smith L.G., Weissman I.L., Heimfeld S. Clonal analysis of hematopoietic stem-cell differentiation invivo. Proc. Natl. Acad. Sci. USA 1991, 88:2788-2792.
32. Song C.X., Szulwach K.E., Fu Y., Dai Q., Yi C., Li X., Li Y., Chen C.H., Zhang W., Jian X., et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 2011, 29:68-72.
33. Spradling A., Drummond-Barbosa D., Kai T. Stem cells find their niche. Nature 2001, 414:98-104.
34. Stroud H., Feng S., Morey Kinney S., Pradhan S., Jacobsen S.E. 5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells. Genome Biol. 2011, 12:R54.
35. Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
36. Tallack M.R., Whitington T., Yuen W.S., Wainwright E.N., Keys J.R., Gardiner B.B., Nourbakhsh E., Cloonan N., Grimmond S.M., Bailey T.L., Perkins A.C. A global role for KLF1 in erythropoiesis revealed by ChIP-seq in primary erythroid cells. Genome Res. 2010, 20:1052-1063.
37. Tamez P.A., Liu H., Fernandez-Pol S., Haldar K., Wickrema A. Stage-specific susceptibility of human erythroblasts to Plasmodium falciparum malaria infection. Blood 2009, 114:3652-3655.
38. Tefferi A., Lim K.H., Abdel-Wahab O., Lasho T.L., Patel J., Patnaik M.M., Hanson C.A., Pardanani A., Gilliland D.G., Levine R.L. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 2009, 23:1343-1345.
39. Uda M., Galanello R., Sanna S., Lettre G., Sankaran V.G., Chen W., Usala G., Busonero F., Maschio A., Albai G., et al. Genome-wide association study shows BCL11A associated with persistent fetal hemoglobin and amelioration of the phenotype of beta-thalassemia. Proc. Natl. Acad. Sci. USA 2008, 105:1620-1625.
40. Uddin S., Ah-Kang J., Ulaszek J., Mahmud D., Wickrema A. Differentiation stage-specific activation of p38 mitogen-activated protein kinase isoforms in primary human erythroid cells. Proc. Natl. Acad. Sci. USA 2004, 101:147-152.
41. Williams R.T., Wang Y. A density functional theory study on the kinetics and thermodynamics of N-glycosidic bond cleavage in 5-substituted 2'-deoxycytidines. Biochemistry 2012, 51:6458-6462.
42. Williams K., Christensen J., Pedersen M.T., Johansen J.V., Cloos P.A., Rappsilber J., Helin K. TET1 and hydroxymethylcytosine in transcription and DNA methylation fidelity. Nature 2011, 473:343-348.
43. Wossidlo M., Nakamura T., Lepikhov K., Marques C.J., Zakhartchenko V., Boiani M., Arand J., Nakano T., Reik W., Walter J. 5-Hydroxymethylcytosine in the mammalian zygote is linked with epigenetic reprogramming. Nat Commun 2011, 2:241.
44. Wu H., Zhang Y. Mechanisms and functions of Tet protein-mediated 5-methylcytosine oxidation. Genes Dev. 2011, 25:2436-2452.
45. Wu H., Zhang Y. Tet1 and 5-hydroxymethylation: a genome-wide view in mouse embryonic stem cells. Cell Cycle 2011, 10:2428-2436.
46. Wu H., D'Alessio A.C., Ito S., Wang Z., Cui K., Zhao K., Sun Y.E., Zhang Y. Genome-wide analysis of 5-hydroxymethylcytosine distribution reveals its dual function in transcriptional regulation in mouse embryonic stem cells. Genes Dev. 2011, 25:679-684.
47. Xu W., Yang H., Liu Y., Yang Y., Wang P., Kim S.H., Ito S., Yang C., Wang P., Xiao M.T., et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell 2011, 19:17-30.
48. Xu J., Shao Z., Glass K., Bauer D.E., Pinello L., Van Handel B., Hou S., Stamatoyannopoulos J.A., Mikkola H.K., Yuan G.C., Orkin S.H. Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis. Dev. Cell 2012, 23:796-811.
49. Xue Y., Lim S., Yang Y., Wang Z., Jensen L.D., Hedlund E.M., Andersson P., Sasahara M., Larsson O., Galter D., et al. PDGF-BB modulates hematopoiesis and tumor angiogenesis by inducing erythropoietin production in stromal cells. Nat. Med. 2012, 18:100-110.
50. Yamazaki J., Taby R., Vasanthakumar A., Macrae T., Ostler K.R., Shen L., Kantarjian H.M., Estecio M.R., Jelinek J., Godley L.A., Issa J.P. Effects of TET2 mutations on DNA methylation in chronic myelomonocytic leukemia. Epigenetics 2012, 7:201-207.
51. Yu M., Hon G.C., Szulwach K.E., Song C.X., Jin P., Ren B., He C. Tet-assisted bisulfite sequencing of 5-hydroxymethylcytosine. Nat. Protoc. 2012, 7:2159-2170.
52. Yu Y., Mo Y., Ebenezer D., Bhattacharyya S., Liu H., Sundaravel S., Giricz O., Wontakal S., Cartier J., Caces B., et al. High resolution methylome analysis reveals widespread functional hypomethylation during adult human erythropoiesis. J.Biol. Chem. 2013, 288:8805-8814.